Cargando…
What can be learned from the history of recurrence in migraine? A comment
Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatriptan. The history of recurrence in early sumatriptan randomised clinical trials is described. Recurrence has been ascribed to patient-dependent factors but experience with ergot alkaloids suggested that recurrenc...
Autor principal: | Tfelt-Hansen, Peer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452092/ https://www.ncbi.nlm.nih.gov/pubmed/19705060 http://dx.doi.org/10.1007/s10194-009-0144-0 |
Ejemplares similares
-
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
por: Tfelt-Hansen, Peer
Publicado: (2007) -
Permeability of dura mater: a possible link between cortical spreading depression and migraine pain? A comment
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010) -
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment
por: Tfelt-Hansen, Peer C.
Publicado: (2009) -
Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008) -
CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)